TALPHERA, INC. Cost of Services, Overhead (Deprecated 2018-01-31)
TALPHERA, INC. (TLPH) reported Cost of Services, Overhead (Deprecated 2018-01-31) of $200.00 thousand for the 9-month period ending 2013-09-30, per its 10-Q filed 2013-11-05.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfServicesOverhead · last filed 2013-11-05
- TALPHERA, INC. cost of services, overhead (deprecated 2018-01-31) for the quarter ending 2013-09-30 was $0.00.
- TALPHERA, INC. cost of services, overhead (deprecated 2018-01-31) for the quarter ending 2013-06-30 was $0.00.
- TALPHERA, INC. cost of services, overhead (deprecated 2018-01-31) for the quarter ending 2013-03-31 was $200.00K.
| Period end | Cost of Services, Overhead (Deprecated 2018-01-31) 3 month | Cost of Services, Overhead (Deprecated 2018-01-31) 6 month | Cost of Services, Overhead (Deprecated 2018-01-31) 9 month |
|---|---|---|---|
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | $0.00 derived: sum of 2 quarters · filed 2013-11-05 | $200.00K 10-Q · filed 2013-11-05 |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | $200.00K 10-Q · filed 2013-08-12 | |
| 2013-03-31 | $200.00K 10-Q · filed 2013-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |